Global Castrate-resistant Prostate Cancer Treatment Market Research Report 2023

Castrate-resistant Prostate Cancer Treatment Market

Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. Also called CRPC.

The global Castrate-resistant Prostate Cancer Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Castrate-resistant Prostate Cancer Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Castrate-resistant Prostate Cancer Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Castrate-resistant Prostate Cancer Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Castrate-resistant Prostate Cancer Treatment include Sanofi, Johnson & Johnson Services, Inc., Pfizer, Inc., Astellas Pharma, Inc. and Bayer AG, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Castrate-resistant Prostate Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Castrate-resistant Prostate Cancer Treatment.

The Castrate-resistant Prostate Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Castrate-resistant Prostate Cancer Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Castrate-resistant Prostate Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Castrate-resistant Prostate Cancer Treatment Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Castrate-resistant Prostate Cancer Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Chemotherapy

1.2.3 Hormonal Therapy

1.2.4 Immunotherapy

1.2.5 Radiotherapy

1.3 Market by Application

1.3.1 Global Castrate-resistant Prostate Cancer Treatment Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Castrate-resistant Prostate Cancer Treatment Market Perspective (2018-2029)

2.2 Castrate-resistant Prostate Cancer Treatment Growth Trends by Region

2.2.1 Global Castrate-resistant Prostate Cancer Treatment Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Castrate-resistant Prostate Cancer Treatment Historic Market Size by Region (2018-2023)

2.2.3 Castrate-resistant Prostate Cancer Treatment Forecasted Market Size by Region (2024-2029)

2.3 Castrate-resistant Prostate Cancer Treatment Market Dynamics

2.3.1 Castrate-resistant Prostate Cancer Treatment Industry Trends

2.3.2 Castrate-resistant Prostate Cancer Treatment Market Drivers

2.3.3 Castrate-resistant Prostate Cancer Treatment Market Challenges

2.3.4 Castrate-resistant Prostate Cancer Treatment Market Restraints

3.1 Global Top Castrate-resistant Prostate Cancer Treatment Players by Revenue

3.1.1 Global Top Castrate-resistant Prostate Cancer Treatment Players by Revenue (2018-2023)

3.1.2 Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Players (2018-2023)

3.2 Global Castrate-resistant Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Castrate-resistant Prostate Cancer Treatment Revenue

3.4 Global Castrate-resistant Prostate Cancer Treatment Market Concentration Ratio

3.4.1 Global Castrate-resistant Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Castrate-resistant Prostate Cancer Treatment Revenue in 2022

3.5 Castrate-resistant Prostate Cancer Treatment Key Players Head office and Area Served

3.6 Key Players Castrate-resistant Prostate Cancer Treatment Product Solution and Service

3.7 Date of Enter into Castrate-resistant Prostate Cancer Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Castrate-resistant Prostate Cancer Treatment Historic Market Size by Type (2018-2023)

4.2 Global Castrate-resistant Prostate Cancer Treatment Forecasted Market Size by Type (2024-2029)

5.1 Global Castrate-resistant Prostate Cancer Treatment Historic Market Size by Application (2018-2023)

5.2 Global Castrate-resistant Prostate Cancer Treatment Forecasted Market Size by Application (2024-2029)

6.1 North America Castrate-resistant Prostate Cancer Treatment Market Size (2018-2029)

6.2 North America Castrate-resistant Prostate Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2018-2023)

6.4 North America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Castrate-resistant Prostate Cancer Treatment Market Size (2018-2029)

7.2 Europe Castrate-resistant Prostate Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Country (2018-2023)

7.4 Europe Castrate-resistant Prostate Cancer Treatment Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size (2018-2029)

8.2 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Region (2018-2023)

8.4 Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Castrate-resistant Prostate Cancer Treatment Market Size (2018-2029)

9.2 Latin America Castrate-resistant Prostate Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2018-2023)

9.4 Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size (2018-2029)

10.2 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Country (2018-2023)

10.4 Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Sanofi

11.1.1 Sanofi Company Detail

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Castrate-resistant Prostate Cancer Treatment Introduction

11.1.4 Sanofi Revenue in Castrate-resistant Prostate Cancer Treatment Business (2018-2023)

11.1.5 Sanofi Recent Development

11.2 Johnson & Johnson Services, Inc.

11.2.1 Johnson & Johnson Services, Inc. Company Detail

11.2.2 Johnson & Johnson Services, Inc. Business Overview

11.2.3 Johnson & Johnson Services, Inc. Castrate-resistant Prostate Cancer Treatment Introduction

11.2.4 Johnson & Johnson Services, Inc. Revenue in Castrate-resistant Prostate Cancer Treatment Business (2018-2023)

11.2.5 Johnson & Johnson Services, Inc. Recent Development

11.3 Pfizer, Inc.

11.3.1 Pfizer, Inc. Company Detail

11.3.2 Pfizer, Inc. Business Overview

11.3.3 Pfizer, Inc. Castrate-resistant Prostate Cancer Treatment Introduction

11.3.4 Pfizer, Inc. Revenue in Castrate-resistant Prostate Cancer Treatment Business (2018-2023)

11.3.5 Pfizer, Inc. Recent Development

11.4 Astellas Pharma, Inc.

11.4.1 Astellas Pharma, Inc. Company Detail

11.4.2 Astellas Pharma, Inc. Business Overview

11.4.3 Astellas Pharma, Inc. Castrate-resistant Prostate Cancer Treatment Introduction

11.4.4 Astellas Pharma, Inc. Revenue in Castrate-resistant Prostate Cancer Treatment Business (2018-2023)

11.4.5 Astellas Pharma, Inc. Recent Development

11.5 Bayer AG

11.5.1 Bayer AG Company Detail

11.5.2 Bayer AG Business Overview

11.5.3 Bayer AG Castrate-resistant Prostate Cancer Treatment Introduction

11.5.4 Bayer AG Revenue in Castrate-resistant Prostate Cancer Treatment Business (2018-2023)

11.5.5 Bayer AG Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Castrate-resistant Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Chemotherapy

    Table 3. Key Players of Hormonal Therapy

    Table 4. Key Players of Immunotherapy

    Table 5. Key Players of Radiotherapy

    Table 6. Global Castrate-resistant Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Castrate-resistant Prostate Cancer Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Castrate-resistant Prostate Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Castrate-resistant Prostate Cancer Treatment Market Share by Region (2018-2023)

    Table 10. Global Castrate-resistant Prostate Cancer Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Castrate-resistant Prostate Cancer Treatment Market Share by Region (2024-2029)

    Table 12. Castrate-resistant Prostate Cancer Treatment Market Trends

    Table 13. Castrate-resistant Prostate Cancer Treatment Market Drivers

    Table 14. Castrate-resistant Prostate Cancer Treatment Market Challenges

    Table 15. Castrate-resistant Prostate Cancer Treatment Market Restraints

    Table 16. Global Castrate-resistant Prostate Cancer Treatment Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Castrate-resistant Prostate Cancer Treatment Market Share by Players (2018-2023)

    Table 18. Global Top Castrate-resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castrate-resistant Prostate Cancer Treatment as of 2022)

    Table 19. Ranking of Global Top Castrate-resistant Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Castrate-resistant Prostate Cancer Treatment Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Castrate-resistant Prostate Cancer Treatment Product Solution and Service

    Table 23. Date of Enter into Castrate-resistant Prostate Cancer Treatment Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Castrate-resistant Prostate Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Type (2018-2023)

    Table 27. Global Castrate-resistant Prostate Cancer Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Type (2024-2029)

    Table 29. Global Castrate-resistant Prostate Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Application (2018-2023)

    Table 31. Global Castrate-resistant Prostate Cancer Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Castrate-resistant Prostate Cancer Treatment Revenue Market Share by Application (2024-2029)

    Table 33. North America Castrate-resistant Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Castrate-resistant Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Castrate-resistant Prostate Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Castrate-resistant Prostate Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Castrate-resistant Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Castrate-resistant Prostate Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Sanofi Company Detail

    Table 49. Sanofi Business Overview

    Table 50. Sanofi Castrate-resistant Prostate Cancer Treatment Product

    Table 51. Sanofi Revenue in Castrate-resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)

    Table 52. Sanofi Recent Development

    Table 53. Johnson & Johnson Services, Inc. Company Detail

    Table 54. Johnson & Johnson Services, Inc. Business Overview

    Table 55. Johnson & Johnson Services, Inc. Castrate-resistant Prostate Cancer Treatment Product

    Table 56. Johnson & Johnson Services, Inc. Revenue in Castrate-resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)

    Table 57. Johnson & Johnson Services, Inc. Recent Development

    Table 58. Pfizer, Inc. Company Detail

    Table 59. Pfizer, Inc. Business Overview

    Table 60. Pfizer, Inc. Castrate-resistant Prostate Cancer Treatment Product

    Table 61. Pfizer, Inc. Revenue in Castrate-resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)

    Table 62. Pfizer, Inc. Recent Development

    Table 63. Astellas Pharma, Inc. Company Detail

    Table 64. Astellas Pharma, Inc. Business Overview

    Table 65. Astellas Pharma, Inc. Castrate-resistant Prostate Cancer Treatment Product

    Table 66. Astellas Pharma, Inc. Revenue in Castrate-resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)

    Table 67. Astellas Pharma, Inc. Recent Development

    Table 68. Bayer AG Company Detail

    Table 69. Bayer AG Business Overview

    Table 70. Bayer AG Castrate-resistant Prostate Cancer Treatment Product

    Table 71. Bayer AG Revenue in Castrate-resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)

    Table 72. Bayer AG Recent Development

    Table 73. Research Programs/Design for This Report

    Table 74. Key Data Information from Secondary Sources

    Table 75. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Castrate-resistant Prostate Cancer Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Castrate-resistant Prostate Cancer Treatment Market Share by Type: 2022 VS 2029

    Figure 3. Chemotherapy Features

    Figure 4. Hormonal Therapy Features

    Figure 5. Immunotherapy Features

    Figure 6. Radiotherapy Features

    Figure 7. Global Castrate-resistant Prostate Cancer Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Castrate-resistant Prostate Cancer Treatment Market Share by Application: 2022 VS 2029

    Figure 9. Hospital Case Studies

    Figure 10. Clinics Case Studies

    Figure 11. Others Case Studies

    Figure 12. Castrate-resistant Prostate Cancer Treatment Report Years Considered

    Figure 13. Global Castrate-resistant Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Castrate-resistant Prostate Cancer Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Castrate-resistant Prostate Cancer Treatment Market Share by Region: 2022 VS 2029

    Figure 16. Global Castrate-resistant Prostate Cancer Treatment Market Share by Players in 2022

    Figure 17. Global Top Castrate-resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castrate-resistant Prostate Cancer Treatment as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Castrate-resistant Prostate Cancer Treatment Revenue in 2022

    Figure 19. North America Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Castrate-resistant Prostate Cancer Treatment Market Share by Country (2018-2029)

    Figure 21. United States Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Castrate-resistant Prostate Cancer Treatment Market Share by Country (2018-2029)

    Figure 25. Germany Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Castrate-resistant Prostate Cancer Treatment Market Share by Region (2018-2029)

    Figure 33. China Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Castrate-resistant Prostate Cancer Treatment Market Share by Country (2018-2029)

    Figure 41. Mexico Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Castrate-resistant Prostate Cancer Treatment Market Share by Country (2018-2029)

    Figure 45. Turkey Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Castrate-resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Sanofi Revenue Growth Rate in Castrate-resistant Prostate Cancer Treatment Business (2018-2023)

    Figure 48. Johnson & Johnson Services, Inc. Revenue Growth Rate in Castrate-resistant Prostate Cancer Treatment Business (2018-2023)

    Figure 49. Pfizer, Inc. Revenue Growth Rate in Castrate-resistant Prostate Cancer Treatment Business (2018-2023)

    Figure 50. Astellas Pharma, Inc. Revenue Growth Rate in Castrate-resistant Prostate Cancer Treatment Business (2018-2023)

    Figure 51. Bayer AG Revenue Growth Rate in Castrate-resistant Prostate Cancer Treatment Business (2018-2023)

    Figure 52. Bottom-up and Top-down Approaches for This Report

    Figure 53. Data Triangulation

    Figure 54. Key Executives Interviewed